-+ 0.00%
-+ 0.00%
-+ 0.00%

Neurocrine Biosciences Reports Valbenazine Fails to Meet Endpoints in Dyskinetic Cerebral Palsy Trial

Reuters·12/22/2025 21:05:52

Please log in to view news